| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $729K | +78.2% | +31.4% |
| Cost of Revenue | $294K | +85.8% | +54.0% |
| R&D Expense | $1.4M | -2.3% | -40.0% |
| SG&A Expense | $1.5M | -8.6% | -3.5% |
| Operating Income | -$3.7M | +5.1% | +28.6% |
| Pre-tax Income | -$4.2M | +8.5% | +22.4% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | +42.0% | -40.0% |
| Accounts Receivable | $572K | +124.8% | +51.3% |
| Inventory | $5.8M | +10.5% | +198.5% |
| Current Assets | $12.2M | +25.6% | +8.4% |
| Total Assets | $16.3M | +18.2% | +4.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.5M | — | — |
| Capital Expenditures | $385K | — | — |
| Investing Cash Flow | -$433K | — | — |
| Financing Cash Flow | $16.1M | — | — |
| Free Cash Flow | -$14.9M | — | — |
| — |
| -100.0% |
| Net Income | -$4.2M | +8.5% | +22.4% |
| EPS (Basic) | -$0.10 | +37.5% | +58.3% |
| EPS (Diluted) | -$0.10 | +37.5% | +58.3% |
| $10.5M |
| -3.8% |
| +267.6% |
| Total Liabilities | $11.7M | -4.4% | +22.0% |
| Stockholders' Equity | $4.6M | +202.3% | -23.7% |